 | • レポートコード：GIR-23F3800 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Duck Virus Enteritis Vaccine Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のアヒルウイルス腸炎ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 アヒルウイルス腸炎ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、不活化ワクチン アプリケーション別セグメントは次のように区分されます。 ・鴨、その他 世界のアヒルウイルス腸炎ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・Ceva Santé Animale、Chengdu TECBOND Biological、Institute of Animal Health and Veterinary Biologicals、Institute of Veterinary Preventive Medicine、International Duck Research Cooperative、MSD Animal Health (Merck)、Ringpu (Tianjin)Bio-Pharmacy、Veterinary Research Institute 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - アヒルウイルス腸炎ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、不活化ワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：鴨、その他 - 世界のアヒルウイルス腸炎ワクチン市場規模・予測 - 世界のアヒルウイルス腸炎ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Ceva Santé Animale、Chengdu TECBOND Biological、Institute of Animal Health and Veterinary Biologicals、Institute of Veterinary Preventive Medicine、International Duck Research Cooperative、MSD Animal Health (Merck)、Ringpu (Tianjin)Bio-Pharmacy、Veterinary Research Institute ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、不活化ワクチン ・アプリケーション別分析2017年-2028年：鴨、その他 ・アヒルウイルス腸炎ワクチンの北米市場分析 - アヒルウイルス腸炎ワクチンの北米市場：タイプ別市場規模2017年-2028年 - アヒルウイルス腸炎ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・アヒルウイルス腸炎ワクチンのヨーロッパ市場分析 - ：アヒルウイルス腸炎ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：アヒルウイルス腸炎ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・アヒルウイルス腸炎ワクチンのアジア太平洋市場分析 - アヒルウイルス腸炎ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - アヒルウイルス腸炎ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・アヒルウイルス腸炎ワクチンの南米市場分析 - アヒルウイルス腸炎ワクチンの南米市場：タイプ別市場規模2017年-2028年 - アヒルウイルス腸炎ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・アヒルウイルス腸炎ワクチンの中東・アフリカ市場分析 - アヒルウイルス腸炎ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - アヒルウイルス腸炎ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Duck Virus Enteritis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Duck Virus Enteritis Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Duck accounting for % of the Duck Virus Enteritis Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Duck Virus Enteritis Vaccine include Ceva Santé Animale, Chengdu TECBOND Biological, Institute of Animal Health and Veterinary Biologicals, Institute of Veterinary Preventive Medicine, and International Duck Research Cooperative, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Duck Virus Enteritis Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Duck
Others
The key market players for global Duck Virus Enteritis Vaccine market are listed below:
Ceva Santé Animale
Chengdu TECBOND Biological
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
International Duck Research Cooperative
MSD Animal Health (Merck)
Ringpu (Tianjin)Bio-Pharmacy
Veterinary Research Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Duck Virus Enteritis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Duck Virus Enteritis Vaccine, with price, sales, revenue and global market share of Duck Virus Enteritis Vaccine from 2019 to 2022.
Chapter 3, the Duck Virus Enteritis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Duck Virus Enteritis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Duck Virus Enteritis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Duck Virus Enteritis Vaccine.
Chapter 13, 14, and 15, to describe Duck Virus Enteritis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Duck Virus Enteritis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Duck Virus Enteritis Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Duck Virus Enteritis Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Duck
1.3.3 Others
1.4 Global Duck Virus Enteritis Vaccine Market Size & Forecast
1.4.1 Global Duck Virus Enteritis Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Duck Virus Enteritis Vaccine Sales in Volume (2017-2028)
1.4.3 Global Duck Virus Enteritis Vaccine Price (2017-2028)
1.5 Global Duck Virus Enteritis Vaccine Production Capacity Analysis
1.5.1 Global Duck Virus Enteritis Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Duck Virus Enteritis Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Duck Virus Enteritis Vaccine Market Drivers
1.6.2 Duck Virus Enteritis Vaccine Market Restraints
1.6.3 Duck Virus Enteritis Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Ceva Santé Animale
2.1.1 Ceva Santé Animale Details
2.1.2 Ceva Santé Animale Major Business
2.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Product and Services
2.1.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Chengdu TECBOND Biological
2.2.1 Chengdu TECBOND Biological Details
2.2.2 Chengdu TECBOND Biological Major Business
2.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product and Services
2.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Institute of Animal Health and Veterinary Biologicals
2.3.1 Institute of Animal Health and Veterinary Biologicals Details
2.3.2 Institute of Animal Health and Veterinary Biologicals Major Business
2.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product and Services
2.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Institute of Veterinary Preventive Medicine
2.4.1 Institute of Veterinary Preventive Medicine Details
2.4.2 Institute of Veterinary Preventive Medicine Major Business
2.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product and Services
2.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 International Duck Research Cooperative
2.5.1 International Duck Research Cooperative Details
2.5.2 International Duck Research Cooperative Major Business
2.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product and Services
2.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 MSD Animal Health (Merck)
2.6.1 MSD Animal Health (Merck) Details
2.6.2 MSD Animal Health (Merck) Major Business
2.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product and Services
2.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Ringpu (Tianjin)Bio-Pharmacy
2.7.1 Ringpu (Tianjin)Bio-Pharmacy Details
2.7.2 Ringpu (Tianjin)Bio-Pharmacy Major Business
2.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product and Services
2.7.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Veterinary Research Institute
2.8.1 Veterinary Research Institute Details
2.8.2 Veterinary Research Institute Major Business
2.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Product and Services
2.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Duck Virus Enteritis Vaccine Breakdown Data by Manufacturer
3.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Duck Virus Enteritis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Duck Virus Enteritis Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Duck Virus Enteritis Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Duck Virus Enteritis Vaccine Manufacturer Market Share in 2021
3.5 Global Duck Virus Enteritis Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Duck Virus Enteritis Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Duck Virus Enteritis Vaccine Market Size by Region
4.1.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Duck Virus Enteritis Vaccine Revenue by Region (2017-2028)
4.2 North America Duck Virus Enteritis Vaccine Revenue (2017-2028)
4.3 Europe Duck Virus Enteritis Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Duck Virus Enteritis Vaccine Revenue (2017-2028)
4.5 South America Duck Virus Enteritis Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Duck Virus Enteritis Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Duck Virus Enteritis Vaccine Revenue by Type (2017-2028)
5.3 Global Duck Virus Enteritis Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Duck Virus Enteritis Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Duck Virus Enteritis Vaccine Revenue by Application (2017-2028)
6.3 Global Duck Virus Enteritis Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Duck Virus Enteritis Vaccine Sales by Type (2017-2028)
7.2 North America Duck Virus Enteritis Vaccine Sales by Application (2017-2028)
7.3 North America Duck Virus Enteritis Vaccine Market Size by Country
7.3.1 North America Duck Virus Enteritis Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Duck Virus Enteritis Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Duck Virus Enteritis Vaccine Sales by Type (2017-2028)
8.2 Europe Duck Virus Enteritis Vaccine Sales by Application (2017-2028)
8.3 Europe Duck Virus Enteritis Vaccine Market Size by Country
8.3.1 Europe Duck Virus Enteritis Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Duck Virus Enteritis Vaccine Market Size by Region
9.3.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Duck Virus Enteritis Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Duck Virus Enteritis Vaccine Sales by Type (2017-2028)
10.2 South America Duck Virus Enteritis Vaccine Sales by Application (2017-2028)
10.3 South America Duck Virus Enteritis Vaccine Market Size by Country
10.3.1 South America Duck Virus Enteritis Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Duck Virus Enteritis Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Duck Virus Enteritis Vaccine Market Size by Country
11.3.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Duck Virus Enteritis Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Duck Virus Enteritis Vaccine
12.3 Duck Virus Enteritis Vaccine Production Process
12.4 Duck Virus Enteritis Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Duck Virus Enteritis Vaccine Typical Distributors
13.3 Duck Virus Enteritis Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Duck Virus Enteritis Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Duck Virus Enteritis Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 4. Ceva Santé Animale Major Business
Table 5. Ceva Santé Animale Duck Virus Enteritis Vaccine Product and Services
Table 6. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Chengdu TECBOND Biological Basic Information, Manufacturing Base and Competitors
Table 8. Chengdu TECBOND Biological Major Business
Table 9. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product and Services
Table 10. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Institute of Animal Health and Veterinary Biologicals Basic Information, Manufacturing Base and Competitors
Table 12. Institute of Animal Health and Veterinary Biologicals Major Business
Table 13. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product and Services
Table 14. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Institute of Veterinary Preventive Medicine Basic Information, Manufacturing Base and Competitors
Table 16. Institute of Veterinary Preventive Medicine Major Business
Table 17. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product and Services
Table 18. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. International Duck Research Cooperative Basic Information, Manufacturing Base and Competitors
Table 20. International Duck Research Cooperative Major Business
Table 21. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product and Services
Table 22. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. MSD Animal Health (Merck) Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health (Merck) Major Business
Table 25. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product and Services
Table 26. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Ringpu (Tianjin)Bio-Pharmacy Basic Information, Manufacturing Base and Competitors
Table 28. Ringpu (Tianjin)Bio-Pharmacy Major Business
Table 29. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product and Services
Table 30. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 32. Veterinary Research Institute Major Business
Table 33. Veterinary Research Institute Duck Virus Enteritis Vaccine Product and Services
Table 34. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Duck Virus Enteritis Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Duck Virus Enteritis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Duck Virus Enteritis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Duck Virus Enteritis Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Duck Virus Enteritis Vaccine Production Site of Key Manufacturer
Table 40. Duck Virus Enteritis Vaccine New Entrant and Capacity Expansion Plans
Table 41. Duck Virus Enteritis Vaccine Mergers & Acquisitions in the Past Five Years
Table 42. Global Duck Virus Enteritis Vaccine Sales by Region (2017-2022) & (K Units)
Table 43. Global Duck Virus Enteritis Vaccine Sales by Region (2023-2028) & (K Units)
Table 44. Global Duck Virus Enteritis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Duck Virus Enteritis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Global Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Global Duck Virus Enteritis Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Duck Virus Enteritis Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Duck Virus Enteritis Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Duck Virus Enteritis Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Global Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Global Duck Virus Enteritis Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Duck Virus Enteritis Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Duck Virus Enteritis Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Duck Virus Enteritis Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. North America Duck Virus Enteritis Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. North America Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Duck Virus Enteritis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. North America Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. North America Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. North America Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Duck Virus Enteritis Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Duck Virus Enteritis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Europe Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Europe Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Europe Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Duck Virus Enteritis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Duck Virus Enteritis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. South America Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)
Table 83. South America Duck Virus Enteritis Vaccine Sales by Country (2023-2028) & (K Units)
Table 84. South America Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Duck Virus Enteritis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. South America Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. South America Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. South America Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Duck Virus Enteritis Vaccine Raw Material
Table 99. Key Manufacturers of Duck Virus Enteritis Vaccine Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Duck Virus Enteritis Vaccine Typical Distributors
Table 103. Duck Virus Enteritis Vaccine Typical Customers
List of Figures
Figure 1. Duck Virus Enteritis Vaccine Picture
Figure 2. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application in 2021
Figure 6. Duck
Figure 7. Others
Figure 8. Global Duck Virus Enteritis Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Duck Virus Enteritis Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Duck Virus Enteritis Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Duck Virus Enteritis Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global Duck Virus Enteritis Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Duck Virus Enteritis Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Duck Virus Enteritis Vaccine Market Drivers
Figure 15. Duck Virus Enteritis Vaccine Market Restraints
Figure 16. Duck Virus Enteritis Vaccine Market Trends
Figure 17. Global Duck Virus Enteritis Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Duck Virus Enteritis Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Duck Virus Enteritis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Duck Virus Enteritis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Duck Virus Enteritis Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Duck Virus Enteritis Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Duck Virus Enteritis Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Duck Virus Enteritis Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Duck Virus Enteritis Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Duck Virus Enteritis Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Duck Virus Enteritis Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Duck Virus Enteritis Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Duck Virus Enteritis Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Duck Virus Enteritis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Duck Virus Enteritis Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Duck Virus Enteritis Vaccine
Figure 77. Duck Virus Enteritis Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
• 日本語訳：アヒルウイルス腸炎ワクチンのグローバル市場2022年
• レポートコード：GIR-23F3800 ▷ お問い合わせ（見積依頼・ご注文・質問）